| |
| |
|
| Insider
Information: |
Osborne David W |
| Relationship: |
Chief Technical Officer |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
268,854 |
|
|
Indirect Shares
|
124,956 |
|
|
| Direct
Value |
$2,150,832 |
|
|
|
Indirect Value
|
$999,648 |
|
|
| Total
Shares |
393,810 |
|
|
| Total
Value |
$3,150,480 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arcutis Biotherapeutics, Inc. |
ARQT |
Chief Technical Officer |
2023-03-06 |
268,854 |
2020-12-14 |
124,956 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2023-03-06 |
4 |
AS |
$15.26 |
$10,532 |
D/D |
(690) |
268,854 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,900 |
269,544 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2023-03-02 |
4 |
AS |
$15.82 |
$19,198 |
D/D |
(1,213) |
254,644 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2023-02-28 |
4 |
AS |
$16.17 |
$12,804 |
D/D |
(792) |
255,857 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2022-07-08 |
4 |
AS |
$25.41 |
$55,835 |
D/D |
(2,197) |
256,649 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2022-04-21 |
4 |
AS |
$20.42 |
$44,872 |
D/D |
(2,197) |
257,229 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2022-03-07 |
4 |
AS |
$16.44 |
$460 |
D/D |
(28) |
259,426 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2022-03-04 |
4 |
AS |
$16.86 |
$13,959 |
D/D |
(828) |
259,454 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,300 |
260,282 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2022-03-01 |
4 |
AS |
$17.75 |
$13,758 |
D/D |
(775) |
246,982 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,500 |
246,753 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2021-03-01 |
4 |
AS |
$34.57 |
$26,968 |
D/D |
(780) |
237,253 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2020-12-14 |
4 |
AS |
$30.00 |
$450,000 |
D/D |
(15,000) |
250,533 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2020-09-29 |
4 |
AS |
$30.00 |
$450,000 |
D/D |
(15,000) |
264,279 |
0 |
% |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
279,279 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical Officer |
• – – |
2020-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
24,991 |
270,279 |
0 |
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical OfficerOfficer |
• – – |
2020-01-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
124,956 |
|
- |
|
| ARQT |
Arcutis Biotherapeutics, ... |
Chief Technical OfficerOfficer |
• – – |
2020-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
254,288 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
